Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Merrimack Pharmaceuticals, Inc. MACK

Set alert

Price alert · MACK

All alert types
15.15 0.00 0.00%

As of May 17, 3:59 PM ET

15.14 Day range 15.17

52-week range unavailable

Open
15.15
Prev close
15.15
Mkt cap
223.97M
Vol
922.50K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
100.00%
More statistics
Low
15.14
High
15.17
Forward P/E
-8.50
Beta
1.42
Short ratio
8.65
Inst. own
62.98%
Dividend
15.10
Ex-div date
May 8, 2024
Earnings
May 15, 2024
50-d avg
14.84
200-d avg
13.48
1y target
0.00

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Mar 7, 2024Earnings: —; estimate 0; surprise —%
  • May 9, 2024Dividend: 15.1
  • May 15, 2024Earnings: —; estimate 0; surprise —%
  • May 20, 2024Dividend: 15.1
Signals (8)
NameDateAgo
MACD: Sell SignalMay 22, 20242 years ago
MACD: Buy SignalMay 1, 20242 years ago
RSI: OverboughtMay 1, 20242 years ago
SMA: BullishApr 19, 20242 years ago
SMA: BearishApr 12, 20242 years ago
SMA: BullishApr 9, 20242 years ago
MACD: Sell SignalMar 1, 20242 years ago
RSI: OverboughtMar 1, 20242 years ago

Financial health

Altman Z-Score

5.01 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -162×
FY 2014: -11.1×FY 2015: -4.7×FY 2016: -2.7×FY 2017: 0.2×FY 2018: -1.0×FY 2019: -2.0×FY 2020: -30.0×FY 2021: -21.7×FY 2022: -104×FY 2023: -162×
FY 2014 5y median -30.0× FY 2023
P/S 0.0×
FY 2014: 9.0×FY 2015: 7.8×FY 2016: 2.8×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2014 5y median 0.0× FY 2023
P/B 10.2×
FY 2014: -9.1×FY 2015: -3.8×FY 2016: -1.6×FY 2017: 1.1×FY 2018: 0.7×FY 2019: 2.4×FY 2020: 5.8×FY 2021: 3.7×FY 2022: 8.1×FY 2023: 10.2×
FY 2014 5y median 5.8× FY 2023
P/FCF -126×
FY 2014: -22.7×FY 2015: -5.9×FY 2016: -2.3×FY 2017: -0.7×FY 2018: -0.6×FY 2019: -1.3×FY 2020: -19.9×FY 2021: -240×FY 2022: -89.0×FY 2023: -126×
FY 2014 5y median -89.0× FY 2023
EV/EBITDA 85.4×
FY 2014: -15.3×FY 2015: -6.1×FY 2016: -5.4×FY 2017: -0.1×FY 2018: -0.5×FY 2019: -1.3×FY 2020: -27.2×FY 2021: -15.5×FY 2022: -78.4×FY 2023: 85.4×
FY 2014 5y median -15.5× FY 2023
EV/Sales 0.0×
FY 2014: 9.9×FY 2015: 8.6×FY 2016: 4.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2014 5y median 0.0× FY 2023
FCF Yield -0.8%
FY 2014: -4.4%FY 2015: -17.1%FY 2016: -43.1%FY 2017: -137.7%FY 2018: -162.0%FY 2019: -74.6%FY 2020: -5.0%FY 2021: -0.4%FY 2022: -1.1%FY 2023: -0.8%
FY 2014 5y median -1.1% FY 2023

Profitability

Gross Margin 0.0%
FY 2014: 100.0%FY 2015: 99.9%FY 2016: 95.2%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023
Operating Margin 0.0%
FY 2014: -64.5%FY 2015: -145.2%FY 2016: -76.3%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023
Net Margin 0.0%
FY 2014: -81.1%FY 2015: -165.8%FY 2016: -105.2%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023
ROE -6.3%
FY 2014: 81.5%FY 2015: 80.4%FY 2016: 60.4%FY 2017: 490.2%FY 2018: -68.9%FY 2019: -122.8%FY 2020: -18.9%FY 2021: -17.3%FY 2022: -8.0%FY 2023: -6.3%
FY 2014 5y median -17.3% FY 2023
ROIC -11.6%
FY 2014: -104.3%FY 2015: -96.2%FY 2016: 1493.6%FY 2017: -63.0%FY 2018: -78.9%FY 2019: -120.8%FY 2020: -17.9%FY 2021: -17.4%FY 2022: -9.0%FY 2023: -11.6%
FY 2014 5y median -17.4% FY 2023
ROA -6.2%
FY 2014: -52.5%FY 2015: -63.0%FY 2016: -186.2%FY 2017: 402.3%FY 2018: -45.7%FY 2019: -105.9%FY 2020: -18.0%FY 2021: -16.6%FY 2022: -7.8%FY 2023: -6.2%
FY 2014 5y median -16.6% FY 2023

Growth (YoY)

Revenue 0.0%
FY 2014: 115.0%FY 2015: -13.1%FY 2016: 61.6%FY 2017: -100.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 FY 2023
Operating Income -25.9%
FY 2014: 45.0%FY 2015: -95.6%FY 2016: 15.0%FY 2017: 13.1%FY 2018: 31.5%FY 2019: 65.9%FY 2020: 87.2%FY 2021: 14.0%FY 2022: 30.1%FY 2023: -25.9%
FY 2014 FY 2023
EPS (diluted) 24.9%
FY 2014: 39.7%FY 2015: -66.5%FY 2016: 8.9%FY 2017: 394.5%FY 2018: -108.5%FY 2019: 47.7%FY 2020: 85.5%FY 2021: 21.7%FY 2022: 38.9%FY 2023: 24.9%
FY 2014 FY 2023
Free Cash Flow 12.6%
FY 2014: 61.1%FY 2015: -189.3%FY 2016: -46.8%FY 2017: 15.3%FY 2018: 55.3%FY 2019: 52.3%FY 2020: 85.3%FY 2021: 95.3%FY 2022: -699.1%FY 2023: 12.6%
FY 2014 FY 2023

Financial Health

Current Ratio 43.5×
FY 2014: 1.2×FY 2015: 1.9×FY 2016: 0.7×FY 2017: 4.8×FY 2018: 5.1×FY 2019: 6.7×FY 2020: 21.5×FY 2021: 26.1×FY 2022: 33.7×FY 2023: 43.5×
FY 2014 5y median 26.1× FY 2023
Quick Ratio 43.5×
FY 2014: 1.2×FY 2015: 1.9×FY 2016: 0.5×FY 2017: 4.8×FY 2018: 5.1×FY 2019: 6.7×FY 2020: 21.5×FY 2021: 26.1×FY 2022: 33.7×FY 2023: 43.5×
FY 2014 5y median 26.1× FY 2023
Debt / Equity 0.0×
FY 2014: -1.2×FY 2015: -1.4×FY 2016: -0.9×FY 2017: 0.0×FY 2018: 0.3×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2014 5y median 0.0× FY 2023
Net Debt / EBITDA -2.8×
FY 2014: -1.3×FY 2015: -0.6×FY 2016: -1.8×FY 2017: 1.0×FY 2018: 0.1×FY 2019: 0.9×FY 2020: 4.9×FY 2021: 5.7×FY 2022: 11.2×FY 2023: -2.8×
FY 2014 5y median 4.9× FY 2023
Interest Coverage 0.0×
FY 2014: -3.6×FY 2015: -6.7×FY 2016: -2.5×FY 2017: -2.8×FY 2018: -68.6×FY 2019: -14.6×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2014 5y median 0.0× FY 2023

Dividends

Dividend Yield 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 131.3%FY 2018: 0.0%FY 2019: 63.5%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2014: -0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 29.7%FY 2018: 0.0%FY 2019: -125.5%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31